GTC
PHAT icon

Ghost Tree Capital’s Phathom Pharmaceuticals PHAT Stock Holding History

Ghost Tree Capital’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$6.78M Sell
375,000
-225,000
-38% -$3.14M 2.05% 20
2024
Q2 		$6.18M Buy
600,000
+115,000
+24% +$1.18M 1.94% 20
2024
Q1 		$5.15M Buy
485,000
+99,759
+26% +$847K 1.43% 26
2023
Q4 		$3.52M Sell
385,241
-9,759
-2% -$84.1K 1.15% 28
2023
Q3 		$4.1M Buy
395,000
+240,750
+156% +$3.3M 1.35% 28
2023
Q2 		$2.21M Buy
+154,250
New +$1.78M 0.73% 36

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Ghost Tree Capital's PHAT Position: Q3 2024 in Review

Ghost Tree Capital reduced its Phathom Pharmaceuticals (PHAT) stake by 38% in Q3 2024, selling an estimated $3.14M and leaving 375,000 shares worth $6.78M. The position accounts for 2.05% of the portfolio, ranked #20.

Ghost Tree Capital first reported a position in PHAT in Q2 2023 and has held it in 6 quarters since. 133 funds tracked by Wall St. Rank hold PHAT as of Q3 2024.

  • Ghost Tree Capital held 375,000 shares of Phathom Pharmaceuticals worth $6.78M as of Q3 2024.
  • Ghost Tree Capital sold 225,000 Phathom Pharmaceuticals shares in Q3 2024, an estimated $3.14M.
  • Phathom Pharmaceuticals made up 2.05% of Ghost Tree Capital's portfolio in Q3 2024, its #20 holding.
  • Ghost Tree Capital first reported a position in Phathom Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • 133 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.